tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RCUS Stock Latest News

Arcus Biosciences TBA Spot Secondary; price range $18.25-$18.75
The FlyArcus Biosciences TBA Spot Secondary; price range $18.25-$18.75
11h ago
RCUS
Arcus Biosciences announces common stock offering, no amount given
PremiumThe Fly
Arcus Biosciences announces common stock offering, no amount given
12h ago
RCUS
Arcus Biosciences price target raised to $16 from $14 at Goldman Sachs
PremiumThe Fly
Arcus Biosciences price target raised to $16 from $14 at Goldman Sachs
21h ago
RCUS
Arcus Biosciences price target raised to $35 from $33 at Wedbush
PremiumThe Fly
Arcus Biosciences price target raised to $35 from $33 at Wedbush
2d ago
RCUS
Arcus Biosciences price target raised to $56 from $54 at Citi
PremiumThe Fly
Arcus Biosciences price target raised to $56 from $54 at Citi
2d ago
RCUS
Arcus Biosciences price target raised to $28 from $24 at H.C. Wainwright
PremiumThe FlyArcus Biosciences price target raised to $28 from $24 at H.C. Wainwright
2d ago
RCUS
Arcus Biosciences Reports Promising Q3 2025 Results
Premium
Company Announcements
Arcus Biosciences Reports Promising Q3 2025 Results
2d ago
RCUS
Arcus Biosciences reports Q3 EPS ($1.27), consensus ($1.29)
Premium
The Fly
Arcus Biosciences reports Q3 EPS ($1.27), consensus ($1.29)
3d ago
RCUS
Arcus Biosciences Advances Cancer Treatment with AB801 Study
PremiumCompany Announcements
Arcus Biosciences Advances Cancer Treatment with AB801 Study
3d ago
RCUS
Arcus Biosciences Advances Phase 3 Trial for Renal Cell Carcinoma
PremiumCompany Announcements
Arcus Biosciences Advances Phase 3 Trial for Renal Cell Carcinoma
3d ago
RCUS
Arcus Biosciences’ Promising Phase 1 Study on Renal Cell Carcinoma
PremiumCompany Announcements
Arcus Biosciences’ Promising Phase 1 Study on Renal Cell Carcinoma
3d ago
RCUS
Taiho exercises option to develop, commercialize casdatifan in Japan, Asia
PremiumThe Fly
Taiho exercises option to develop, commercialize casdatifan in Japan, Asia
11d ago
RCUS
Arcus Biosciences Reports Promising Phase 2 Study Results
PremiumCompany AnnouncementsArcus Biosciences Reports Promising Phase 2 Study Results
17d ago
8K
RCUS
Arcus Biosciences price target raised to $54 from $47 at Citi
Premium
The Fly
Arcus Biosciences price target raised to $54 from $47 at Citi
18d ago
RCUS
Positive Outlook for Arcus Biosciences Driven by Promising Phase 2 Trial Results and Broader Patient Applicability
Premium
Ratings
Positive Outlook for Arcus Biosciences Driven by Promising Phase 2 Trial Results and Broader Patient Applicability
18d ago
RCUS
Arcus announces first OS results from Arm A1 of Phase 2 EDGE-Gastric study
PremiumThe Fly
Arcus announces first OS results from Arm A1 of Phase 2 EDGE-Gastric study
18d ago
RCUS
Arcus Biosciences price target raised to $39 from $32 at Truist
PremiumThe Fly
Arcus Biosciences price target raised to $39 from $32 at Truist
24d ago
RCUS
Arcus Biosciences’ Casdatifan Shows Superior Efficacy and Safety in ccRCC Treatment, Supporting Buy Rating
PremiumRatings
Arcus Biosciences’ Casdatifan Shows Superior Efficacy and Safety in ccRCC Treatment, Supporting Buy Rating
24d ago
RCUS
Arcus Biosciences: Promising Efficacy and Manageable Safety Profile Drive Buy Rating
PremiumRatings
Arcus Biosciences: Promising Efficacy and Manageable Safety Profile Drive Buy Rating
25d ago
RCUS
Truist says Arcus Biosciences data for Casdatifan ‘looks like a home run’
PremiumThe FlyTruist says Arcus Biosciences data for Casdatifan ‘looks like a home run’
25d ago
RCUS
Arcus Biosciences Presents Promising ARC-20 Study Data
Premium
Company Announcements
Arcus Biosciences Presents Promising ARC-20 Study Data
25d ago
8K
RCUS
Arcus Biosciences announces new data for casdatifan
Premium
The Fly
Arcus Biosciences announces new data for casdatifan
25d ago
RCUS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >